SunStar Healthcare, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From SunStar Healthcare, Inc.
Draft US FDA Guidance Outlines Heightened Expectations On Sterility Of Non-Sterile Drugs
More testing expected after B. cepacia contamination of OTC liquid drug products, including for Rx drug products.
US FDA Guidance On B. Cepacia Contamination Coming Soon, CDER Director Cavazzoni Says
Agency will provide guidance in wake of recent outbreaks of Burkholderia cepacia in non-sterile, water-based drug products.
Company Information
- Industry
- Services
-
Services
- Services sold to health care facilities
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice